Milton C. Ault III - 19 Sep 2025 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director, 10%+ Owner
Signature
/s/ Milton C. Ault, III
Issuer symbol
ALZN
Transactions as of
19 Sep 2025
Net transactions value
-$180,856
Form type
4
Filing time
23 Sep 2025, 16:30:08 UTC
Previous filing
19 Sep 2025
Next filing
25 Sep 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Milton C. Ault III filed Form 4 for Alzamend Neuro, Inc. (ALZN) on 23 Sep 2025."

Quick Takeaways

  • This page summarizes Milton C. Ault III's Form 4 filing for Alzamend Neuro, Inc. (ALZN).
  • 3 reported transactions and 4 derivative rows are listed below.
  • Filing timestamp: 23 Sep 2025, 16:30.

What Changed

  • Previous filing in this sequence was filed on 19 Sep 2025.
  • Current net transaction value: -$180,856.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
AULT MILTON C III Director, 10%+ Owner 11411 SOUTHERN HIGHLANDS PARKWAY, SUITE 190, LAS VEGAS /s/ Milton C. Ault, III 23 Sep 2025 0001212502

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Sale $180,856 -77,009 -90% $2.35 8,260 19 Sep 2025 By Ault Lending, LLC F1
transaction ALZN Common Stock Conversion of derivative security $232,000 +100,000 +1211% $2.32 108,260 22 Sep 2025 By Ault Lending, LLC F1, F2
holding ALZN Common Stock 1,843 19 Sep 2025 Direct
holding ALZN Common Stock 11,068 19 Sep 2025 By Ault Life Sciences, Inc. F3
holding ALZN Common Stock 61 19 Sep 2025 By Ault Life Sciences Fund, LLC F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALZN Series B Convertible Preferred Stock Conversion of derivative security $232,000 -232 -18% $1000.00 1,071 22 Sep 2025 Common Stock 100,000 $2.32 By Ault Lending, LLC F1, F5, F6
holding ALZN Common Stock Purchase Warrants 13,556 19 Sep 2025 Common Stock 13,556 $108.00 By Ault Lending, LLC F1
holding ALZN Common Stock Purchase Warrants 8,667 19 Sep 2025 Common Stock 8,667 $108.00 By Ault Lending, LLC F1
holding ALZN Common Stock Purchase Warrants 1,111 19 Sep 2025 Common Stock 1,111 $108.00 By Ault Lending, LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F2 Represents shares of common stock received upon conversion of Series B convertible preferred stock ("Series B Preferred").
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F4 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.
F5 The Conversion Price of the Series B Preferred is subject to adjustment as set forth in that certain Designation of Preferences, Rights and Limitations of the Series B Convertible Voting Preferred Stock.
F6 The shares of Series B Preferred have no expiration date.

Sponsored